Search clinical trials for: [F-18]W372

Total 12142 results

Siemens Molecular Imaging

Completed

Exploratory and Safety Study of [F-18]W372

Alzheimer's Disease

United States
Vivasure Medical Limited

Completed

Safety and Performance Study of Large Hole Vascular Closure Device (Frontier-III)

18 to 24 F Percutaneous Femoral Arteriotomy Closure

Germany
Assiut University

Not yet recruiting

Kidney Uptake at F-18 FDG PET/CT Studies and Renal Function Status

Renal Uptake at F-18-FDG PET/CT
Chang Gung Memorial Hospital

Completed

Novel Neuroimage Study in Tauopathies With Parkinsonism

Parkinsonism

Taiwan
Siemens Molecular Imaging
Fudan University

Completed

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Head and Neck Cancer | Lung Cancer | Liver Cancer

China
Chang Gung Memorial Hospital

Completed

18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls

Frontotemporal Dementia | Progressive Supranuclear Palsy | Alzheimer's Disease | Vascular Cognitive Impairment | Cortical Basal Syndrome

Taiwan
John M. Buatti
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers

Uterine Cervical Neoplasms | Prostatic Neoplasms | Rectal Neoplasms | Endometrial Neoplasms | Anus Neoplasms

United States
Siemens Molecular Imaging

Completed

A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation (FLT101)

Head and Neck Cancer | Lung Cancer

United States
ABX advanced biochemical compounds GmbH

Completed

F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence

Prostate Cancer | Prostate Cancer Recurrent

France
Chang Gung Memorial Hospital

Completed

Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)

Major Depressive Disorder

Taiwan
Avid Radiopharmaceuticals

Completed

A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation

Alzheimer Disease

United States
Northwell Health

Completed

Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)

Neuroendocrine Tumors

United States
Brigham and Women's Hospital

Terminated

Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography

Cardiac Amyloidosis

United States
Case Comprehensive Cancer Center

Withdrawn

Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease

Malignant Neoplasm of Prostate

United States
Brigham and Women's Hospital

Completed

Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA

MSA

United States
Chang Gung Memorial Hospital

Completed

Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph ) (PET)

Alzheimer's Disease
University of Alabama at Birmingham

Recruiting

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States
University of California, Los Angeles

Completed

Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy

TBI (Traumatic Brain Injury) | CTE

United States
Chang Gung Memorial Hospital

Recruiting

Image Characteristic and Longitudinal Follow up of 18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear Palsy

Progressive Supranuclear Palsy

Taiwan
Brigham and Women's Hospital

Unknown

Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease (MAPET)

Multiple Sclerosis | Alzheimer's Disease

United States
Siemens Molecular Imaging

Withdrawn

A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients

Head and Neck Cancer

United States
Siemens Molecular Imaging

Completed

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

Brain Cancer

United States
Technische Universität Dresden

Completed

Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET

Head and Neck Cancer

Germany
The Catholic University of Korea

Unknown

Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Korea, Republic of
FutureChem

Recruiting

Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis

High Risk Prostate Carcinoma

Korea, Republic of
Chang Gung Memorial Hospital

Recruiting

Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects

Alzheimer's Disease

Taiwan
Eli Lilly and Company

Completed

A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Alzheimer Disease

United States, Japan, United Kingdom
Avid Radiopharmaceuticals

Terminated

Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

Alzheimer's Disease

United States
National Cancer Centre, Singapore
Terry Fox Foundation

Completed

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

Nasopharyngeal Carcinoma

Singapore
Siemens Molecular Imaging

Terminated

[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

Carotid Stenosis

United States
Bayer

Completed

Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers

Alzheimer's Disease | Positron-Emission Tomography

Netherlands, Sweden
National Institute of Mental Health (NIMH)

Completed

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB

Healthy | Neurocysticercosis

United States
Brigham and Women's Hospital
Biohaven Pharmaceuticals, Inc.

Completed

Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients

Multiple System Atrophy | Multiple System Atrophy, Parkinson Variant (Disorder) | Multiple System Atrophy, Cerebellar Variant | Multiple System Atrophy (MSA) With Orthostatic Hypotension

United States
Davidzon, Guido, M.D.

Terminated

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Osteosarcoma

United States
Mayo Clinic

Recruiting

Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia (SLD3)

Primary Progressive Aphasia | Behavioral Variant of Frontotemporal Dementia | Frontotemporal Dementia, Behavioral Variant

United States
University of Michigan
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)

Parkinson Disease | Progressive Supranuclear Palsy

United States
Avid Radiopharmaceuticals

Completed

Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects

Alzheimer Disease

United States
Tadashi Watabe

Recruiting

Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts

Neoplasms

Japan
Tammie L. S. Benzinger, MD, PhD

Completed

F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected

Alzheimer Disease | HIV

United States
Bayer

Completed

Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

Diagnostic Imaging

Finland, Netherlands
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 (T808)

Alzheimers Disease

United States
Bayer

Completed

Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients

Neoplasm

Germany
University of California, Los Angeles

Withdrawn

FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD (FDDNP)

Suspected Chronic Traumatic Encephalopathy (CTE) or Traumatic Encephalopathy Syndrome (TES) | Suspected Alzheimer's Disease (AD)
Siemens Molecular Imaging

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 (K5)

Melanoma | Sarcoma | Breast Cancer | Lung Cancer | High Grade Gliomas

United States
Wake Forest University Health Sciences
Lucerno Dynamics, LLC

Terminated

Infiltration Effect on SUV

Dose Response Relationship, Drug

United States
Technische Universität Dresden

Completed

Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET

Lung Cancer

Germany
Chang Gung Memorial Hospital

Unknown

Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination (PMPBB3/AV45)

Alzheimer's Disease

Taiwan
Technische Universität Dresden
Advanced Biochemical Compounds GmbH

Terminated

F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response

Brain Tumor

Germany
Yaakov Stern
National Institute on Aging (NIA)

Completed

Imaging of Cognition, Learning, and Memory in Aging

Alzheimer's Disease

United States
University of California, Irvine

Withdrawn

Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation

Head and Neck Cancer

United States

Search clinical trials for: [F-18]W372

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations